Both medications received approval from the FDA in 2017. Ozempic (semaglutide injection) and Fiasp (insulin aspart injection), two recently-approved diabetes treatments, are now available in U.S.

Anavip contains venom-specific F(ab’)2 fragments of immunoglobulin G that bind and neutralize venom toxins. Novo Nordisk announced the availability of Ozempic (semaglutide) injection 1mg as a single ...

Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

Credit: Getty Images. Wegovy is a glucagon-like peptide-1 receptor agonist. Certain dosage strengths of Wegovy (semaglutide) will be in short supply through September 2023, according to Novo Nordisk.

Eli Lilly (Indianapolis, IN, US) and Novo Nordisk (Bagsvaerd, Denmark) have announced that the supply of their GLP-1 weight loss drugs has improved, with the FDA shortages database now reporting ...

According to Sahpra, GLP-1-containing products, like Ozempic, which help lower blood-sugar levels and promote weight loss, are being made available to the public through websites, social media, and ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Hilary Brueck Every time Hilary publishes a story, you’ll get an alert straight to your inbox!

SAN ANTONIO — They're calling it "Faux-Zempic" or fake Ozempic. First there was a shortage of medication, but now fake versions are landing increasing numbers of people in the ER. A big problem with ...

The manufacturers of Ozempic and Mounjaro are creating oral weight loss medications that could change treatment methods.